1917
It is founded
Istituto Gentili
1917-97
Marketing
of products under the
Istituto Gentili brand
2009
The
Mediolanum
pharmaceutical group
takes over the Istituto Gentili
from Merck Sharp & Dohme
Italia group
2017
AcquisitionTherabel
by the Mediolanum Pharmaceutical group
2017
With the deal with
Novartis Farma S.p.Athe new reality of Istituto Gentili
is born,
entirely focused on
oncology
2018
The
acquisition of
Teva's Italia Srl OncoCare products
further strengthens
the Portfolio of
Istituto Gentili's products
2020
Acquisition
of 3 products
that allowed to expand the
company's response
to the fight
against breast cancer
2021
Acquisition of one product dedicated to supportive
therapies for cancer patients.
